PL2276505T3 - Sprej do nosa lub krople do nosa do leczenia przeziębienia - Google Patents
Sprej do nosa lub krople do nosa do leczenia przeziębieniaInfo
- Publication number
- PL2276505T3 PL2276505T3 PL09721305T PL09721305T PL2276505T3 PL 2276505 T3 PL2276505 T3 PL 2276505T3 PL 09721305 T PL09721305 T PL 09721305T PL 09721305 T PL09721305 T PL 09721305T PL 2276505 T3 PL2276505 T3 PL 2276505T3
- Authority
- PL
- Poland
- Prior art keywords
- nasal
- treatment
- common cold
- drops
- spray
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0800658 | 2008-03-20 | ||
EP09721305.2A EP2276505B1 (en) | 2008-03-20 | 2009-03-20 | Nasal spray or nasal drops for treatment of common cold |
PCT/SE2009/050291 WO2009116944A1 (en) | 2008-03-20 | 2009-03-20 | Use of a substance for manufacturing of a medicament for treatment of common cold |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2276505T3 true PL2276505T3 (pl) | 2014-01-31 |
Family
ID=41091160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL09721305T PL2276505T3 (pl) | 2008-03-20 | 2009-03-20 | Sprej do nosa lub krople do nosa do leczenia przeziębienia |
Country Status (8)
Country | Link |
---|---|
US (1) | US8895282B2 (pl) |
EP (1) | EP2276505B1 (pl) |
JP (1) | JP5558458B2 (pl) |
CN (1) | CN101977625A (pl) |
DK (1) | DK2276505T3 (pl) |
ES (1) | ES2436037T3 (pl) |
PL (1) | PL2276505T3 (pl) |
WO (1) | WO2009116944A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015166197A1 (en) | 2014-04-30 | 2015-11-05 | Matoke Holdings Limited | Antimicrobial compositions |
US10213491B2 (en) * | 2015-05-19 | 2019-02-26 | The Penn State Research Foundation | Glucose oxidase compositions as a neonate anticonvulsant |
JPWO2017033616A1 (ja) * | 2015-08-21 | 2018-06-07 | 森永乳業株式会社 | 上気道保護剤及び上気道保護用飲食品組成物 |
JP2019533661A (ja) * | 2016-10-06 | 2019-11-21 | マトケ・ホールディングス・リミテッド | 抗微生物組成物 |
GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
WO2019136168A1 (en) | 2018-01-03 | 2019-07-11 | Penn State Research Foundation | Glucose oxidase compositions as a neonate anticonvulsant |
US20190388465A1 (en) * | 2018-06-25 | 2019-12-26 | Triumph Pharmaceuticals Inc. | Methods of inhibiting microbial infections using zinc-containing compositions |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8702831L (sv) | 1987-07-10 | 1989-01-11 | Ewos Ab | Microbicid komposition |
GB9002422D0 (en) * | 1990-02-03 | 1990-04-04 | Boots Co Plc | Anti-microbial compositions |
US5389369A (en) * | 1991-02-21 | 1995-02-14 | Exoxemis, Inc. | Halo peroxidase containing compositions for killing yeast and sporular microorganisms |
WO1992014484A1 (en) | 1991-02-21 | 1992-09-03 | Exoxemis, Inc. | Methods and compositions for the treatment of infection and control of flora |
GB2285218A (en) * | 1993-12-17 | 1995-07-05 | William Elwyn Roberts | An aid to recovery from disease caused by bacteria fungi viruses and malignant cells |
GB9406075D0 (en) | 1994-03-26 | 1994-05-18 | Boots Co Plc | Method of killing microorganisms |
SE506529C2 (sv) * | 1996-01-23 | 1997-12-22 | Semper Ab | Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori |
CO4910145A1 (es) * | 1996-10-01 | 2000-04-24 | Smithkline Beecham Corp | Uso |
WO1999002148A1 (en) * | 1997-07-11 | 1999-01-21 | The Johns Hopkins University School Of Medicine | Nitric oxide inhibits rhinovirus infection |
DE29723959U1 (de) * | 1997-07-22 | 1999-07-22 | Zellner, Gerhard, Dr., 83435 Bad Reichenhall | Nasenspray-Flüssigkeit |
JP2003516314A (ja) * | 1999-09-17 | 2003-05-13 | スミスクライン・ビーチャム・コーポレイション | ライノウイルス感染症におけるcsaidの使用 |
US20040033260A1 (en) * | 1999-10-19 | 2004-02-19 | The Procter & Gamble Company | Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
US6214339B1 (en) * | 2000-01-12 | 2001-04-10 | Michael A. Pellico | Di-enzymatic treatment of outer ear infection in dogs and cats |
AR030753A1 (es) * | 2000-09-25 | 2003-09-03 | Smithkline Beecham Corp | Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas |
SE0200876L (sv) * | 2002-03-22 | 2003-09-23 | Krister Tano | Nässpray mot öroninflammationer |
CN1408358A (zh) * | 2002-09-20 | 2003-04-09 | 高艺歌 | 一种葡萄糖酸锌(胶体)喷鼻剂的处方组成 |
US7968122B2 (en) * | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
WO2005113026A2 (en) * | 2004-04-22 | 2005-12-01 | Medical Discoveries, Inc. | Method of treating respiratory disorders and airway inflammation |
US20070026085A1 (en) * | 2005-07-26 | 2007-02-01 | Global Life Technologies Corp. | Antimicrobial and antiviral composition |
WO2007045251A2 (en) | 2005-10-21 | 2007-04-26 | Danisco A/S | A composition comprising a coupled enzyme system |
-
2009
- 2009-03-20 WO PCT/SE2009/050291 patent/WO2009116944A1/en active Application Filing
- 2009-03-20 US US12/933,438 patent/US8895282B2/en not_active Expired - Fee Related
- 2009-03-20 CN CN2009801100377A patent/CN101977625A/zh active Pending
- 2009-03-20 EP EP09721305.2A patent/EP2276505B1/en not_active Not-in-force
- 2009-03-20 ES ES09721305T patent/ES2436037T3/es active Active
- 2009-03-20 PL PL09721305T patent/PL2276505T3/pl unknown
- 2009-03-20 DK DK09721305.2T patent/DK2276505T3/da active
- 2009-03-20 JP JP2011500740A patent/JP5558458B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20110044966A1 (en) | 2011-02-24 |
JP5558458B2 (ja) | 2014-07-23 |
EP2276505B1 (en) | 2013-09-18 |
EP2276505A4 (en) | 2011-06-22 |
WO2009116944A1 (en) | 2009-09-24 |
CN101977625A (zh) | 2011-02-16 |
US8895282B2 (en) | 2014-11-25 |
EP2276505A1 (en) | 2011-01-26 |
ES2436037T3 (es) | 2013-12-26 |
JP2011515391A (ja) | 2011-05-19 |
DK2276505T3 (da) | 2013-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2282795A4 (en) | TREATMENT OF RESPIRATORY DISEASES | |
EP2049035A4 (en) | NASAL TISSUE TREATMENT SYSTEMS | |
HRP20181608T1 (hr) | Korištenje inhibitora pde7 u liječenju bolesti kretanja | |
EP2303184A4 (en) | GLAUCOMA ASSOCIATION TREATMENT | |
GB0703909D0 (en) | Treatment of anxiety disorders | |
EP2182952A4 (en) | TREATMENT OF POST-TRAUMATIC STRESS DISORDER | |
IL194189A0 (en) | Combination treatment of metabolic disorders | |
EP2120930A4 (en) | USE OF CHROMIHISTIDINATE FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES | |
PL2276505T3 (pl) | Sprej do nosa lub krople do nosa do leczenia przeziębienia | |
ZA201107445B (en) | Compound for the treatment of metabolic disorders | |
PL2247297T3 (pl) | Działanie terapeutyczne w stanach chorobowych płuc | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
EP2184353A4 (en) | TREATMENT OF INFLUENZA | |
GB0809476D0 (en) | Treatment of neurodegenerative disorders | |
EP2328584A4 (en) | TREATMENT OF NEUROLOGICAL DISORDERS USING HUPERZINE | |
GB0723100D0 (en) | Treatment of HFnEF | |
EP2023894A4 (en) | FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE | |
IL210558A0 (en) | Treatment of anxiety disorders | |
HK1158626A1 (en) | Sulfonamide compounds for the treatment of respiratory disorders | |
EP2454229A4 (en) | AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN | |
EP2226119A4 (en) | sputtering | |
HK1139050A1 (en) | Medicament for the treatment of pneumonia | |
EP2240024A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
ZA201100490B (en) | Treatment of thrombocytopenia | |
GB0811625D0 (en) | Treatment of epithelial fragility disorders |